Evogen, Inc. promoted Richard St.Clair to Vice President of
St.Clair previously served as Director of Marketing & Business
Development. In this new assignment, he will be responsible for
spearheading efforts for identification of opportunities and
commercialization of Evogen and Sceptor products for the healthcare,
biodefense, and industrial business segments.
In his previous position as Director, St.Clair was instrumental in
creating customer alliances leading to identification of product needs
and delivering real world solutions to save customers money while
gaining sensitivity and specificity necessary for critical sample
collection and analysis.
Utilizing wide-reaching contacts, St.Clair is experienced and has proven
successful in managing the customer relationship and all phases of
product life cycle including taking products fom ideation and
development to market launch, and rationalization of product portfolios
to revitalize mature products or divest those that have reached the end
of their life cycle. He holds a BA degree in human biology from the
University of Kansas and an MBA from Webster University.
"We are very pleased to welcome Rich to the executive management team.
His knowledge of the industry, practical experience and leadership will
be great assets as we expand our market presence," said Hans
Kastensmith, President and CEO of Evogen.
About Evogen, Inc.
Evogen is dedicated to meeting the molecular diagnostic collection and
detection needs of a diverse range of customers. The Evogen portfolio
includes DNA sample extraction platforms and methodologies, air
collection and monitoring and proprietary PCR probe technology which
provide the user reliable, sensitive and specific answers. Through
careful analysis of the specific needs of each customer, Evogen is able
to deliver systems and solutions that provide rapid results while
lessening the impact on workflow in the laboratory. Visit Evogen.com
About Sceptor Industries, Inc.
Sceptor provides advanced biological system platforms, assays and
reagent kits, and services to detect and identify biological threat
agents. These detection and identification systems are used by the
Federal Government and major systems integrators within the biodefense
industries for a range of specialist applications including building
security, civil defense, and military force protection. These
biodetection systems are distinguished from competition by their
superior performance, stability, ease of use, and affordability.
[ Back To NFVZone's Homepage ]